ArticleFrontiers in surgery2025
Complications and length of stay after enhanced recovery after surgery compared to conventional care in colorectal cancer patients in Northern Italy.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to evaluate postoperative complications and length of stay in colorectal cancer patients undergoing ERAS vs. non-ERAS procedures in a population-based cohort in northern Italy. Methods: Patient characteristics (ASA, tumor site, stage, treatment, BMI) were used. Complications, stratified by Clavien-Dindo and length of stay (LOS), were reported. The odds ratio (OR) and 95% confidence interval (CI) were calculated to evaluate the difference between ERAS and non-ERAS patients. Results: A total of 319 patients were included, divided into the non-ERAS group (113 patients) and the ERAS group (206 patients). Non-ERAS vs. ERAS group showed more complications (16.8% vs. 13.6%; Conclusions: ERAS procedures appear to be able to allow intervention even in older patients and those with comorbidities, without compromising the results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.